美国宣布了一项计划,将把总部位于美国的吉利德科学公司开发的药物Lenacapavir引入HIV疫情严重的国家市场。
美国宣布了一项计划,将把总部位于美国的吉利德科学公司开发的药物Lenacapavir引入HIV疫情严重的国家市场。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.